MEGHAN FOLEY: Open Payments
NPI 1417396565 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 14 payments from 6 companies in 2025. Trend: 2023 $161 · 2024 $218 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $54 |
| Novo Nordisk Inc | 3 | $48 |
| Amgen Inc. | 3 | $46 |
| ABBVIE INC. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: MOUNJARO, EVENITY, VRAYLAR, Ozempic, TRINTELLIX, FARXIGA, AIRSUPRA.
Industry payments across MS — which companies pay providers there.
